These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 37730269)

  • 1. Impact of the COVID-19 pandemic on CVD prevention between different socioeconomic groups in Switzerland.
    Maung KK; Marques-Vidal P
    Open Heart; 2023 Sep; 10(2):. PubMed ID: 37730269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of major cardiovascular risk factors and cardiovascular diseases among Hispanic/Latino individuals of diverse backgrounds in the United States.
    Daviglus ML; Talavera GA; Avilés-Santa ML; Allison M; Cai J; Criqui MH; Gellman M; Giachello AL; Gouskova N; Kaplan RC; LaVange L; Penedo F; Perreira K; Pirzada A; Schneiderman N; Wassertheil-Smoller S; Sorlie PD; Stamler J
    JAMA; 2012 Nov; 308(17):1775-84. PubMed ID: 23117778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in the management of hypertension, diabetes mellitus, and hypercholesterolemia in Korean adults before and during the COVID-19 pandemic: data from the 2010-2020 Korea National Health and Nutrition Examination Survey.
    Kim Y; Park S; Oh K; Choi H; Jeong EK
    Epidemiol Health; 2023; 45():e2023014. PubMed ID: 36731473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The risk of developing cardiovascular disease in Bangladesh: does diabetes mellitus matter? Which socioeconomic status does it impact? A cross sectional study.
    Islam GM
    J Am Soc Hypertens; 2017 Jan; 11(1):45-53.e1. PubMed ID: 27939525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Socioeconomic Status and Adherence to Preventive Measures During the COVID-19 Pandemic in Switzerland: A Population Based Digital Cohort Analysis.
    Tancredi S; van der Linden BWA; Chiolero A; Cullati S; Imboden M; Probst-Hensch N; Keidel D; Witzig M; Dratva J; Michel G; Harju E; Frank I; Lorthe E; Baysson H; Stringhini S; Kahlert CR; Bardoczi JB; Haller ML; Chocano-Bedoya PO; Rodondi N; Amati R; Albanese E; Corna L; Crivelli L; Kaufmann M; Frei A; von Wyl V
    Int J Public Health; 2024; 69():1606861. PubMed ID: 39022447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preterm birth and stillbirth rates associated with socioeconomic disparities during COVID-19 pandemic: a population-based cross-sectional study.
    Aboulatta L; Kowalec K; Leong C; Delaney JA; Falk J; Alessi-Severini S; Chateau D; Tan Q; Kearns K; Raimondi C; Vaccaro C; Lavu A; Haidar L; Peymani P; Eltonsy S
    BMJ Paediatr Open; 2023 Feb; 7(1):. PubMed ID: 36806202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of socioeconomic status on changes in cancer prevention behavior during the COVID-19 pandemic.
    Elsaid MI; Zhang X; Schuster ALR; Plascak JJ; DeGraffinreid C; Paskett ED
    PLoS One; 2023; 18(6):e0287730. PubMed ID: 37390051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence, treatment and control of dyslipidaemia in Switzerland: still a long way to go.
    Firmann M; Marques-Vidal P; Paccaud F; Mooser V; Rodondi N; Waeber G; Vollenweider P
    Eur J Cardiovasc Prev Rehabil; 2010 Dec; 17(6):682-7. PubMed ID: 20700055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of socioeconomic factors on cardiovascular disease risk factors in the context of economic development in the Samoan archipelago.
    Ezeamama AE; Viali S; Tuitele J; McGarvey ST
    Soc Sci Med; 2006 Nov; 63(10):2533-45. PubMed ID: 16876925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in Socioeconomic Status as Predictors of Cardiovascular Disease Incidence and Mortality: A 10-Year Follow-Up of a Polish-Population-Based HAPIEE Cohort.
    Kozela M; Polak M; Stepaniak U; Bobak M; Pająk A
    Int J Environ Res Public Health; 2022 Nov; 19(22):. PubMed ID: 36430130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of socioeconomic status on physical activity and cardiovascular diseases prior to and during the COVID-19 pandemic in the older adults.
    Yang D; Yang SH; Lee JM; Lee JM; Kim J
    Front Public Health; 2023; 11():1241027. PubMed ID: 37771823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Five year trends in dyslipidaemia prevalence and management in Switzerland: the CoLaus study.
    Antiochos P; Marques-Vidal P; Waeber G; Vollenweider P
    Nutr Metab Cardiovasc Dis; 2015 Nov; 25(11):1007-15. PubMed ID: 26321470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Socioeconomic Gradients and Distribution of Diabetes, Hypertension, and Obesity in India.
    Corsi DJ; Subramanian SV
    JAMA Netw Open; 2019 Apr; 2(4):e190411. PubMed ID: 30951154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Race disparities in cardiovascular disease risk factors within socioeconomic status strata.
    Bell CN; Thorpe RJ; Bowie JV; LaVeist TA
    Ann Epidemiol; 2018 Mar; 28(3):147-152. PubMed ID: 29317176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dietary habits mediate the relationship between socio-economic status and CVD factors among healthy adults: the ATTICA study.
    Panagiotakos DB; Pitsavos C; Chrysohoou C; Vlismas K; Skoumas Y; Palliou K; Stefanadis C
    Public Health Nutr; 2008 Dec; 11(12):1342-9. PubMed ID: 18616850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Socioeconomic differentials in trends in the prevalence of hypertension and pre-hypertension and hypertension awareness, treatment, and control in rural Southwestern China.
    Fan LM; Wang F; Zhao M; Cui WL; Cai L
    BMC Cardiovasc Disord; 2021 May; 21(1):259. PubMed ID: 34039284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complexity awareness among university students in Switzerland during the Covid-19 pandemic.
    Nigg C; Benkert R; Tadesse L; Abel T
    Health Promot Int; 2022 Oct; 37(5):. PubMed ID: 36173606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in cardiovascular risk factor prevalence among Lithuanian middle-aged adults between 2009 and 2018.
    Laucevičius A; Rinkūnienė E; Petrulionienė Ž; Ryliškytė L; Jucevičienė A; Puronaitė R; Badarienė J; Navickas R; Mikolaitytė J; Gargalskaitė U; Dženkevičiūtė V; Kutkienė S; Gimžauskaitė S; Mainelis A; Šlapikas R; Gurevičius R; Jatužis D; Kasiulevičius V
    Atherosclerosis; 2020 Apr; 299():9-14. PubMed ID: 32179208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Socioeconomic inequalities in prevalence, awareness, treatment and control of hypertension: evidence from the PERSIAN cohort study.
    Amini M; Moradinazar M; Rajati F; Soofi M; Sepanlou SG; Poustchi H; Eghtesad S; Moosazadeh M; Harooni J; Aghazadeh-Attari J; Fallahi M; Fattahi MR; Ansari-Moghaddam A; Moradpour F; Nejatizadeh A; Shahmoradi M; Mansour-Ghanaei F; Ostadrahimi A; Ahmadi A; Khaledifar A; Saghi MH; Saki N; Mohebbi I; Homayounfar R; Farjam M; Nadimi AE; Kahnooji M; Pourfarzi F; Zamani B; Rezaianzadeh A; Johari MG; Mirzaei M; Dehghani A; Motlagh SFZ; Rahimi Z; Malekzadeh R; Najafi F
    BMC Public Health; 2022 Jul; 22(1):1401. PubMed ID: 35864469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations of socioeconomic status with prevalence, awareness, treatment, and control of hypertension in a general Japanese population: NIPPON DATA2010.
    Satoh A; Arima H; Ohkubo T; Nishi N; Okuda N; Ae R; Inoue M; Kurita S; Murakami K; Kadota A; Fujiyoshi A; Sakata K; Okamura T; Ueshima H; Okayama A; Miura K;
    J Hypertens; 2017 Feb; 35(2):401-408. PubMed ID: 28005709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.